Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats

Japanese Journal of Pharmacology

Volumn 74, Issue 3, 1997, Pages 253-260

  Kawasaki Yatsugi, Sachiko ^a   Yatsugi, Shin Ichi ^a   Koshiya, Kazuo ^a   Shimizu Sasamata, Masao ^a  

^a Inst for Drug Discovery Research   (Japan)

Author keywords

AMPA receptor; Delayed neuronal death; Global cerebral ischemia

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 5,7 DINITRO 2,3 QUINOXALINEDIONE; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GERBIL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CELL NECROSIS; NONHUMAN; RAT; RECTUM TEMPERATURE; TEMPORALIS MUSCLE;

EID: 0030846837     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.74.253     Document Type: Article

References (33)

1. Benveniste H, Drejer J, Schousboe A and Diemer NH: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43, 1369-1374 (1984)
2. Simon R, Swan J, Griffith T and Meldrum B: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852 (1984)
3. Gill R, Foster A and Woodruff GN: Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 7, 3345-3349 (1987)
4. Park CK, Nehls DG, Graham DI, Teasdale GM and McCulloch J: The glutamate antagonist MK801 reduces focal ischaemic brain damage in the rat. Ann Neurol 24, 543-551 (1988)
5. Boast CA, Gerhardt SC, Pastor G, Lehmann J, Etienne PE and Liebman JM: The N-methyl-D-aspartate antagonists CGS19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 442, 345-348 (1988)
6. Minematsu K, Fisher M, Li L and Sotak CH: Diffusion and perfusion magnetic resonance imaging studies to evaluate a non-competitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 24, 2074-2081 (1993)
7. Sauer D, Weber E, Luond G, Silva FD and Allegrini PR: The competitive NMDA antagonist CGP 40116 permanently reduces brain damage after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 15, 602-610 (1995)
8. Koek W, Woods JH and Winger GD: MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245, 969-974 (1988)
9. Morris ROM, Anderson E, Lynch GS and Baudry M: Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776 (1986)
10. Olney JW, Labruyere J and Price M: Pathlogical changes induced in cerebrocortical neurones by phencyclidine and related drugs. Science 244, 1360-1362 (1989)
11. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT and Sesma MA: NMDA antagonist neurotoxicity: mechanism and prevention. Science 254, 1515-1518 (1991)
12. Gill R: The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/Kainate antagonists and the role in cerebral ischaemia.Cerebrovasc Brain Metab Rev 6, 225-256 (1994)
13. Nellgård B and Wieloch T: Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab 12, 2-11 (1992)
14. Buchan AM, Li H and Pulsinelli WA: The N-methyl-D-aspartate antagonist, MK801, fails to protect against neuronal damage caused by transient forebrain ischaemia in adult rats. J Neurosci 11, 1049-1056 (1991)
15. Ohmori J, Sakamoto S, Kubota H, Shimizu-Sasamata M, Okada M, Kawasaki S, Hidaka K, Togami J, Furuya T and Murase K: 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor. J Med Chem 37, 467-475 (1994)
16. Shimizu-Sasamata M, Kawasaki S, Yatsugi S, Ohmori J, Sakamoto S, Koshiya K, Usuda S and Murase K: The neuroprotective action of YM900 (YM90K), a novel and potent AMPA antagonist, in a rat focal ischemia model. J Cereb Blood Flow Metab 13, Supp 1, S664 (1993)
17. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S and Murase K: YM90K: Pharmacological characterization as a selective and potent α-amino-3,5-methylisoxazole-4-propionate (AMPA)/Kainate receptor antagonist. J Pharmacol Exp Ther 276, 84-92 (1996)
18. Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, Koshiya K, Sakamoto S, Uematsu D and Shimizu-Sasamata M: Neuroprotective effect of YM90K, a novel AMPA/Kainate receptor antagonist, in focal ischemia in cats. J Cereb Blood Flow Metab 16, 959-966 (1996)
19. Kirino T: Delayed neuronal death in gerbil hippocampus following ischemia. Brain Res 239, 57-69 (1982)
20. Pulsinelli WA and Brierley JB: A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272 (1979)
21. Giffard RG, Monyer H, Christine CW and Choi DW: Acidosis reduces NMDA receptor activaton, glutamate neurotoxicity, and oxygen-glucose deprivaton neuronal injury in cortical cultures. Brain Res 506, 339-342 (1990)
22. Davis SN, Lester RA, Reymann KG and Collingridge GL: Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature 338, 400-503 (1989)
23. Andiné P, Jacobson I and Hagberg H: Calcium uptake evoked by electrical stimulation is enhanced postischemically and precedes delayed neuonal death in CA1 of rat hippocampus: involvement of N-methyl-D-aspartate receptors. J Cereb Blood Flow Metab 8, 799-807 (1989)
24. Andiné P, Jacobson I and Hagberg H: Enhanced calcium uptake by CA1 pyramidal cell dendrites in the postischemic phase despite subnormal evoked field potentials: Excitatory amino acid receptor dependency and relationship to neuronal damage. J Cereb Blood Flow Metab 12, 773-783 (1992)
25. Pellegrini-Giampietro DE, Zukin RS, Bennett MVL, Cho S and Pulsinelli WA: Swich in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 89, 10499-10503 (1992)
26. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853 (1991)
27. Sheardown MJ, Suzak PD and Nordholm L: AMPA but not NMDA, receptor antagonism is neuroprotective in gerbil ischemia, even when delayed 24 h. Eur J Pharmacol 236, 347-353 (1993)
28. Li H and Buchan AM: Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J Cereb Blood Flow Metab 13, 933-939 (1993)
29. Busto R, Dietrich WD, Globus MYT and Ginsberg MD: Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett 101, 299-304 (1989)
30. Busto R, Dietrich WD, Globus MYT, Valdes I, Scheinberg P and Ginsberg MD: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7, 729-738 (1987)
31. Welsh FA, Smith RE and Harris VA: Mild hypothermia prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab 10, 557-563 (1990)
32. Kuroiwa T, Bonnekoh P and Hossmann KA: Prevention of postischemic-hyperthermia prevents ischemic injury of CA1 neurons in gerbil. J Cereb Blood Flow Metab 10, 550-556 (1990)
33. Nurse S and Corbett D: Neuroprotection after several days of mild, drug induced hypothermia. J Cereb Blood Flow Metab 16, 474-480 (1996)